Clinical Trial

Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production

Study acronym: GENESIS
Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Funding discontinued
Summary
The purpose of this research study is to evaluate the effectiveness of a hybrid Artificial Intelligence-assisted speech therapy model, which combines the use of an AI speech therapist (Jessica) with traditional speech therapy sessions led by a Speech-Language Pathologist (SLP). This study aims to determine whether the hybrid model improves articulation in children more effectively than traditional SLP-only therapy. Over the course of 8 weeks, participants will receive weekly therapy sessions, and those in the hybrid therapy group will also practice with Jessica between sessions. The study will also gather feedback from parents and speech therapists to assess their experiences and satisfaction with treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-08.
Status change: Recruiting → Terminated 2026-07-07
Trial Details
NCT Number NCT07061730
Lead Sponsor Syracuse University
Collaborators: Better Speech
Conditions Speech Sound Disorder
Enrollment 23 participants
Start Date 2025-05-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-09